Doc toxin is a kinase that inactivates elongation factor Tu

Journal of Biological Chemistry

Volumn 289, Issue 11, 2014, Pages 7788-7798

  Cruz, Jonathan W ^a   Rothenbacher, Francesca P ^a   Maehigashi, Tatsuya ^b   Lane, William S ^c   Dunham, Christine M ^b   Woychik, Nancy A ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ELONGATION; ENZYMES; METABOLITES; NUCLEIC ACIDS; PROTEINS;

CATALYTIC SITES; ELONGATION FACTOR; ELONGATION FACTOR TU; ENZYMATIC ACTIVITIES; PHOSPHATE GROUP; PHOSPHORYLATION SITES; POST-TRANSLATIONAL MODIFICATIONS; TRANSLATION ELONGATION;

TOXIC MATERIALS;

DOC TOXIN; ELONGATION FACTOR TU; GUANOSINE TRIPHOSPHATASE; MOCIMYCIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING;

ADENYLYLATION; ANTITOXIN; FIC; GTPASE; PHOSPHORYLATION; POST-TRANSLATIONAL MODIFICATION; PROTEIN SYNTHESIS; TRANSLATION; TRANSLATION ELONGATION FACTORS;

AMINO ACID MOTIFS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGE P1; BINDING SITES; CELL PROLIFERATION; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MASS SPECTROMETRY; MOLECULAR DOCKING SIMULATION; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PEPTIDE ELONGATION FACTOR TU; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PYRIDONES; RECOMBINANT PROTEINS; RNA, MESSENGER; THREONINE; VIRAL PROTEINS;

EID: 84896282895     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.544429     Document Type: Article

References (51)

1. Dawson, C. C., Intapa, C., and Jabra-Rizk, M. A. (2011) "Persisters": survival at the cellular level. PLoS Pathogens 7, e1002121
2. Gerdes, K., and Maisonneuve, E. (2012) Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 66, 103-123
3. Kint, C. I., Verstraeten, N., Fauvart, M., and Michiels, J. (2012) New-found fundamentals of bacterial persistence. Trends Microbiol. 20, 577-585
4. Wang, X., and Wood, T. K. (2011) Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 77, 5577-5583
5. Łobocka, M. B., Rose, D. J., Plunkett, G., 3rd, Rusin, M., Samojedny, A., Lehnherr, H., Yarmolinsky, M. B., and Blattner, F. R. (2004) Genome of bacteriophage P1. J. Bacteriol. 186, 7032-7068
6. Makarova, K. S., Wolf, Y. I., and Koonin, E. V. (2009) Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct 4, 19
7. Pandey, D. P., and Gerdes, K. (2005) Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33, 966-976 (Pubitemid 41430517)
8. Garcia-Pino, A., Balasubramanian, S., Wyns, L., Gazit, E., De Greve, H., Magnuson, R. D., Charlier, D., van Nuland, N. A., and Loris, R. (2010) Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell 142, 101-111
9. Gazit, E., and Sauer, R. T. (1999) The Doc toxin and Phd antidote proteins of the bacteriophage P1 plasmid addiction system form a heterotrimeric complex. J. Biol. Chem. 274, 16813-16818
10. Gazit, E., and Sauer, R. T. (1999) Stability and DNA binding of the Phd protein of the phage P1 plasmid addiction system. J. Biol. Chem. 274, 2652-2657 (Pubitemid 29075343)
11. Lehnherr, H., and Yarmolinsky, M. B. (1995) Addiction protein Phd of plasmid prophage P1 is a substrate of the ClpXP serine protease of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 92, 3274-3277
12. Magnuson, R., Lehnherr, H., Mukhopadhyay, G., and Yarmolinsky, M. B. (1996) Autoregulation of the plasmid addiction operon of bacteriophage P1. J. Biol. Chem. 271, 18705-18710 (Pubitemid 26322737)
13. Magnuson, R., and Yarmolinsky, M. B. (1998) Corepression of the P1 addiction operon by Phd and Doc. J. Bacteriol. 180, 6342-6351 (Pubitemid 28544268)
14. McKinley, J. E., and Magnuson, R. D. (2005) Characterization of the Phd repressor-antitoxin boundary. J. Bacteriol. 187, 765-770 (Pubitemid 40096264)
15. Arbing, M. A., Handelman, S. K., Kuzin, A. P., Verdon, G., Wang, C., Su, M., Rothenbacher, F. P., Abashidze, M., Liu, M., Hurley, J. M., Xiao, R., Acton, T., Inouye, M., Montelione, G. T., Woychik, N. A., and Hunt, J. F. (2010) Crystal structures of Phd-Doc, HigA, and YeeU establish multiple evolutionary links between microbial growth-regulating toxin-antitoxin systems. Structure 18, 996-1010
16. Garcia-Pino, A., Christensen-Dalsgaard, M., Wyns, L., Yarmolinsky, M., Magnuson, R. D., Gerdes, K., and Loris, R. (2008) Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J. Biol. Chem. 283, 30821-30827
17. Liu, M., Zhang, Y., Inouye, M., and Woychik, N. A. (2008) Bacterial addiction module toxin Doc inhibits translation elongation through its association with the 30S ribosomal subunit. Proc. Natl. Acad. Sci. U.S.A. 105, 5885-5890 (Pubitemid 351758467)
18. Kinch, L. N., Yarbrough, M. L., Orth, K., and Grishin, N. V. (2009) Fido, a novel AMPylation domain common to Fic, Doc, and AvrB. PloS One 4, e5818
19. Goepfert, A., Stanger, F. V., Dehio, C., and Schirmer, T. (2013) Conserved inhibitory mechanism and competent ATP binding mode for adenylyl-transferases with Fic fold. PloS One 8, e64901
20. Engel, P., Goepfert, A., Stanger, F. V., Harms, A., Schmidt, A., Schirmer, T., and Dehio, C. (2012) Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins. Nature 482, 107-110
21. Woolery, A. R., Luong, P., Broberg, C. A., and Orth, K. (2010) AMPylation: something old is new again. Front. Microbiol. 1, 113
22. Itzen, A., Blankenfeldt, W., and Goody, R. S. (2011) Adenylylation: renaissance of a forgotten post-translational modification. Trends Biochem. Sci. 36, 221-228
23. Williams, J. J., and Hergenrother, P. J. (2012) Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol. 20, 291-298
24. Castro-Roa, D., Garcia-Pino, A., De Gieter, S., van Nuland, N. A., Loris, R., and Zenkin, N. (2013) The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu. Nat. Chem. Biol. 9, 811-817
25. Tovchigrechko, A., and Vakser, I. A. (2006) GRAMM-X public web server for protein-protein docking. Nucleic Acids Res. 34, W310-314 (Pubitemid 44529784)
26. Phe, EF-Tu, and a GTP analog. Science 270, 1464-1472
27. Lyskov, S., and Gray, J. J. (2008) The RosettaDock server for local protein-protein docking. Nucleic Acids Res. 36, W233-238
28. Mattoo, S., Durrant, E., Chen, M. J., Xiao, J., Lazar, C. S., Manning, G., Dixon, J. E., and Worby, C. A. (2011) Comparative analysis of Histophilus somni immunoglobulin-binding protein A (IbpA) with other Fic domain-containing enzymes reveals differences in substrate and nucleotide specificities. J. Biol. Chem. 286, 32834-32842
29. Xiao, J., Worby, C. A., Mattoo, S., Sankaran, B., and Dixon, J. E. (2010) Structural basis of Fic-mediated adenylylation. Nat. Struct. Mol. Biol. 17, 1004-1010
30. Goepfert, A., Harms, A., Schirmer, T., and Dehio, C. (2013) in Prokaryotic Toxin-Antitoxins (Gerdes, K., ed) pp. 177-187, Sorubger-Verlag, Heidelberg
31. Yarbrough, M. L., Li, Y., Kinch, L. N., Grishin, N. V., Ball, H. L., and Orth, K. (2009) AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 323, 269-272
32. Palanivelu, D. V., Goepfert, A., Meury, M., Guye, P., Dehio, C., and Schirmer, T. (2011) Fic domain-catalyzed adenylylation: insight provided by the structural analysis of the type IV secretion system effector BepA. Protein Sci. 20, 492-499
33. Worby, C. A., Mattoo, S., Kruger, R. P., Corbeil, L. B., Koller, A., Mendez, J. C., Zekarias, B., Lazar, C., and Dixon, J. E. (2009) The Fic domain: regulation of cell signaling by adenylylation. Mol. Cell 34, 93-103
34. Weijland, A., Harmark, K., Cool, R. H., Anborgh, P. H., and Parmeggiani, A. (1992) Elongation factor Tu: a molecular switch in protein biosynthesis. Mol. Microbiol. 6, 683-688
35. Mishra, S., Bhagavat, R., Chandra, N., Vijayarangan, N., Rajeswari, H., and Ajitkumar, P. (2012) Cloning, expression, purification, and biochemical characterisation of the FIC motif containing protein of Mycobacterium tuberculosis. Protein Expression Purification 86, 58-67
36. Mukherjee, S., Liu, X., Arasaki, K., McDonough, J., Galán, J. E., and Roy, C. R. (2011) Modulation of Rab GTPase function by a protein phosphocholine transferase. Nature 477, 103-106
37. Lippmann, C., Lindschau, C., Vijgenboom, E., Schröder, W., Bosch, L., and Erdmann, V. A. (1993) Prokaryotic elongation factor Tu is phosphorylated in vivo. J. Biol. Chem. 268, 601-607 (Pubitemid 23021364)
38. Alexander, C., Bilgin, N., Lindschau, C., Mesters, J. R., Kraal, B., Hilgenfeld, R., Erdmann, V. A., and Lippmann, C. (1995) Phosphorylation of elongation factor Tu prevents ternary complex formation. J. Biol. Chem. 270, 14541-14547
39. Wolf, H., Chinali, G., and Parmeggiani, A. (1974) Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc. Natl. Acad. Sci. U.S.A. 71, 4910-4914
40. Holm, L., and Rosenström, P. (2010) Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545-549
41. Hasegawa, H., and Holm, L. (2009) Advances and pitfalls of protein structural alignment. Curr. Opin. Struct. Biol. 19, 341-348
42. Tan, Y., Arnold, R. J., and Luo, Z. Q. (2011) Legionella pneumophila regulates the small GTPase Rab1 activity by reversible phosphorylcholination. Proc. Natl. Acad. Sci. U.S.A. 108, 21212-21217
43. Gerdes, K., Rasmussen, P. B., and Molin, S. (1986) Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. U.S.A. 83, 3116-3120 (Pubitemid 16042987)
44. Parmeggiani, A., and Swart, G. W. (1985) Mechanism of action of kirromycin-like antibiotics. Annu. Rev. Microbiol. 39, 557-577
45. Berchtold, H., Reshetnikova, L., Reiser, C. O., Schirmer, N. K., Sprinzl, M., and Hilgenfeld, R. (1993) Crystal structure of active elongation factor Tu reveals major domain rearrangements. Nature 365, 126-132 (Pubitemid 23282057)
46. Kjeldgaard, M., Nissen, P., Thirup, S., and Nyborg, J. (1993) The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation. Structure 1, 35-50
47. Kjeldgaard, M., and Nyborg, J. (1992) Refined structure of elongation factor EF-Tu from Escherichia coli. J. Mol. Biol. 223, 721-742
48. Voorhees, R. M., Schmeing, T. M., Kelley, A. C., and Ramakrishnan, V. (2010) The mechanism for activation of GTP hydrolysis on the ribosome. Science 330, 835-838
49. Hopfield, J. J. (1974) Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proc. Natl. Acad. Sci. U.S.A. 71, 4135-4139
50. Ninio, J. (1975) Kinetic amplification of enzyme discrimination. Biochimie 57, 587-595
51. Pereira, S. F., Goss, L., and Dworkin, J. (2011) Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol. Mol. Biol. Rev. 75, 192-212